Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metabolic Health Solutions is an Australian medical technology and digital health company focused on metabolic measurement and precision weight-management care. The company commercializes ECAL, a portable indirect calorimetry device used to assess resting metabolic rate and substrate utilization, and is building METS_iQ, a clinical metabolic intelligence and decision-support platform. MHS also operates clinical metabolic health programs that combine device-based testing, pathology, and lifestyle intervention to support obesity and related metabolic disorders. Its offering is positioned around personalized care for chronic metabolic disease, including support for patients using GLP-1 receptor agonist therapies and in bariatric settings. The company appears to be a revenue-generating commercial medtech rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metabolic Health Solutions.